Christine Fox, EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 21,258 shares at $35.31 ($751K) on 2026-04-30, disclosed to the SEC on 2026-05-04.
Open-market sale of $751k TEVA by EVP, U.S. Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TEVA | SELL | 2025-11-24 | $1.4M | — | Filing → |
| TEVA | SELL | 2025-11-18 | $753K | — | Filing → |
| TEVA | SELL | 2025-03-06 | $161K | — | Filing → |